Drug Hypersensitivity and Desensitizations

Immunol Allergy Clin North Am. 2017 Nov;37(4):xvii-xviii. doi: 10.1016/j.iac.2017.08.002.

Author

Mariana C Castells¹

Affiliation

¹ Drug Hypersensitivity and Desensitization Center, Mastocytosis Center Brigham and Women's Hospital/Dana Farber Cancer Institute, Harvard Medical School, 60 Fenwood Road, Room 5002, Boston, MA 02115, USA; 850 Boylston Street, Brookline, MA 02445, USA. Electronic address: mcastells@partners.org.

PMID: 28965644
DOI: 10.1016/j.iac.2017.08.002

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Anti-Bacterial Agents / adverse effects
Anti-Bacterial Agents / immunology
Anti-Inflammatory Agents, Non-Steroidal / adverse effects
Anti-Inflammatory Agents, Non-Steroidal / immunology
Antibodies, Monoclonal / adverse effects
Antibodies, Monoclonal / immunology
Antineoplastic Agents / adverse effects
Antineoplastic Agents / immunology
Biomarkers / analysis
Desensitization, Immunologic / methods*
Drug Hypersensitivity / diagnosis
Drug Hypersensitivity / etiology
Drug Hypersensitivity / immunology
Drug Hypersensitivity / prevention & control*
Humans
Injections, Subcutaneous
Precision Medicine / methods*
Progesterone / adverse effects
Progesterone / immunology

Substances

Anti-Bacterial Agents
Anti-Inflammatory Agents, Non-Steroidal
Antibodies, Monoclonal
Antineoplastic Agents
Biomarkers
Progesterone